Clinical Trial Update: Dose Response Trial of Pergolide for Cocaine Dependence - 1 [Phase 3]

View source ↗

Summary

Phase 3 dose-response trial evaluating pergolide for cocaine use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• Pergolide (pergolide)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cocaine-Related Disorders | Phase 3 | Status: COMPLETED